$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Therapeutic inhibitor of vascular smooth muscle cells 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-002/00
출원번호 US-0896208 (2001-06-29)
발명자 / 주소
  • Lawrence L. Kunz
  • John M. Reno
출원인 / 주소
  • NeoRx Corporation
대리인 / 주소
    Schwegman, Lundbereg, Woessner & Kluth, P.A.
인용정보 피인용 횟수 : 116  인용 특허 : 349

초록

Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a

대표청구항

1. A kit comprising an implantable device adapted for the delivery of at least one therapeutic agent to a site in the lumen of a traumatized mammalian vessel and a unit dosage form comprising at least one cytoskeletal inhibitor in a liquid vehicle, wherein the administration of at least a portion of

이 특허에 인용된 특허 (349)

  1. Schickaneder Helmut (Poing DEX) Lser Roland (Feldafing DEX) Grill Helmut (Vaterstetten DEX), 1,1,2-triphenylbut-1-ene derivatives.
  2. Crawley Graham C. (Macclesfield GB2), 1-Hydrocarbyloxyphenyl-1,2-diphenylalkene derivatives.
  3. Malamas Michael S. (Jamison PA), 2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-oxazoles as anti-atherosclerotic agents.
  4. Jones C. David (Indianapolis IN) Suarez Tulio (Indianapolis IN), 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents.
  5. Godfrey Alexander G. (Greenwood IN), 2-amino-3-aroyl-benzo[b 상세보기
  • Press Jeffery B. (Bellvale NY) Safir Sidney R. (River Edge NJ), 3,4-Disubstituted thiophenes.
  • Piggott James R. (Bothell WA), 3,4-diarylchromans for inhibiting calmodulin activity.
  • Piggott James R. (Bothell WA), 3,4-diarylchromans for treatment of dermatitis.
  • Btzow Ralf (Helsinki CA FIX) Ruoslahti Erkki (Rancho Santa Fe CA), 60 kDa transforming growth factor-b 상세보기
  • Boyan Barbara D. (San Antonio TX) Schwartz Zvi (San Antonio TX) Bonewald Lynda F. (San Antonio TX), Activation of latent transforming growth factor b 상세보기
  • Beck Lee R. (Birmingham AL) Flowers Charles F. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Tanquary Albert C. (Birmingham AL), Active/passive immunization of the internal female reproductive organs.
  • King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  • King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  • King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  • King Ann C. (Chapel Hill NC), Agents for potentiating the effects of antitumor agents and combating multiple drug resistance.
  • Harper, Michael J. K.; Richardson, Dora N.; Walpole, deceased, Arthur L., Alkene derivatives.
  • Sachs Clifford W. (Durham NC) Fine Robert L. (Durham NC) Ballas Lawrence M (Apex NC) Carroll R. Ivy (Durham NC) Bell Robert (Durham NC), Aminoanthraquinone derivatives to combat multidrug resistance.
  • Sorenson John R. J. (4301 W. Markham Little Rock AK 72201), Analgesic method.
  • Sorenson John R. J. (4301 W. Markham Little Rock AR 72201), Analgesic method.
  • Sorenson John R. J. (4301 W. Markham Little Rock AR 72201), Analgesic method.
  • Hattner Robert S. (Mill Valley CA), Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport.
  • Hattner Robert S. (Mill Valley CA), Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport.
  • Einzig Stanley (Golden Valley MN) Zhang Shu-Lun (Beijing CNX), Anisodamine to prevent and treat eye disease.
  • Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  • Labrie Fernand (Quebec CAX) Merand Yves (Quebec CAX), Anti-estrogenic compounds and compositions.
  • Sorensen John R. J. (1167 Hollywood Ave. Cincinnati OH 45224), Anti-inflammatory and anti-ulcer compounds and process.
  • Sorenson John R. J. (1167 Hollywood Ave. Cincinnati OH 45224), Anti-inflammatory and anti-ulcer compounds and process.
  • Sorenson John R. J. (1167 Hollywood Ave. Cincinnati OH 45224), Anti-inflammatory and anti-ulcer compounds and process.
  • Sorenson John R. J. (1167 Hollywood Ave. Cincinnati OH 45224), Anti-inflammatory and anti-ulcer compounds and process.
  • Harita ; Kozaburo ; Ajisawa ; Yukiyoshi ; Iizuka ; Kinji ; Kinoshita ; Y ukihiko ; Kamijo ; Tetsuhide ; Kobayashi ; Michihiro, Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same.
  • Goers John W. F. (Atascadero CA) King Hurley D. (Yardley PA) Lee Chyi (New Brunswick NJ) Coughlin Daniel J. (Plainsboro NJ) Alvarez Vernon L. (Morrisville PA) Rodwell John D. (Yardley PA) McKearn Tho, Antibody-therapeutic agent conjugates.
  • Holland Gerald F. (Old Lyme CT), Antidiabetic furancarboxylic and thiphenecarboxylic acids.
  • Jones Charles D. (Indianapolis IN), Antiestrogenic and antiandrugenic benzothiophenes.
  • Suarez Tulio (Indianapolis IN) Jones C. David (Indianapolis IN), Antifertility compounds.
  • Suarez Tulio (Indianapolis IN) Jones C. David (Indianapolis IN), Antifertility compounds.
  • Cardin Alan D. (Cincinnati OH) Busch Steven J. (West Chester OH) Mano Masayuki (Izumo JPX), Antiproliferative oligomers.
  • Woods W. T. (R.R. 1-Box 13 Chatham IL 62629), Apparatus and method for angioplasty and for preventing re-stenosis.
  • Harita Kozaburo (Hongo JA) Ajisawa Yukiyoshi (Okaya JA) Iizuka Kinji (Matsumoto JA) Kinoshita Yukihiko (Matsumoto JA) Kamijo Tetsuhide (Shiojiri JA) Kobayashi Michihiro (Toyoshina JA), Aromatic carboxylic amide derivatives.
  • Harita Kozaburo (Osaka JPX) Ajisawa Yukiyoshi (Nagano JPX) Iizuka Kinji (Nagano JPX) Kinoshita Yukihiko (Nagano JPX) Kamijo Tetsuhide (Nagano JPX) Kobayashi Michihiro (Nagano JPX), Aromatic carboxylic amide derivatives.
  • Milius Richard A. (Boston MA) Lambrecht Richard M. (Quogue NY) Bloomer William D. (Wilton CT), Astatinated organic compounds.
  • Venton Duane L. (Villa Park IL) Le Breton Guy C. (Chicago IL) Enke Steven E. (Lutz FL), Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation.
  • Schroeder Daniel (Higganum CT) Lam Kin S. (Cheshire CT) Mattei Jacqueline (East Haven CT) Hesler Grace A. (Branford CT), BMY-41950 antitumor antibiotic.
  • Schroeder Daniel (Higganum CT) Lam Kin S. (Cheshire CT) Mattei Jacqueline (East Haven CT) Hesler Grace A. (Branford CT), BMY-41950 antitumor antibiotic.
  • Shaffer Maureen A. (Miami FL) Leone James E. (Miami FL), Balloon catheter for delivering therapeutic agents.
  • Juhos Tibor (Debrecen HUX) Pl Veronika (Debrecen HUX) Wladimir ne Pap va (Debrecen HUX) Kristf ne Szvitil Ilona (Debrecen HUX) Emri ne Hrsy Zsuzsanna (Debrecen HUX) Papp ne Iski Gabriella (Debrecen H, Beauty preparations having anti-fading effect and a process for preparing the same.
  • Fontana Steven A. (Martinsville IN), Benzofurans used to inhibit bone loss.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN), Benzothiopene compounds, compositions, and method of inhibiting restenosis.
  • Palkowitz Alan D. (Carmel IN), Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN), Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation.
  • Stack Richard S. (Chapel Hill NC) Clark Howard G. (Durham NC) Walker William F. (Holcomb NY) McElhaney James H. (Durham NC), Bioabsorbable stent and method of making the same.
  • McMurray William H. (Firestone CO), Bioavailability enhancers.
  • Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  • Slepian Marvin J. (Cleveland Heights OH) Schindler Anton (Durham NC), Biodegradable polymeric endoluminal sealing process.
  • Narciso ; Jr. Hugh L. (Santa Barbara CA), Biogenic implant for drug delivery and method.
  • Ogawa Yasushi (Pacifica CA) Schmidt David (Santa Cruz CA), Biologically active TGF-b 상세보기
  • Ogawa Yasushi (Pacifica CA) Schmidt David (Santa Cruz CA), Biologically active TGF-b 상세보기
  • Burnier John P. (Pacifica CA) Cianciolo George J. (San Carlos CA), Biologically active polypeptides based on transforming growth factor-b 상세보기
  • Bell Eugene (Dedham MA), Bone-equivalent and method for preparation thereof.
  • Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to.
  • Barath Peter (West Hollywood CA) Denes Ferenc (Budapest HUX), Catheter device for intramural delivery of therapeutic agents.
  • Markaverich Barry M. (The Woodlands TX) Clark James H. (Houston TX) Gregory Rebecca (Houston TX) Alejandro Mary (Houston TX) Middleditch Brian S. (Houston TX) Johnson Gregory A. (Houston TX) Varma Ra, Cell growth inhibitors and methods of treating cancer and cell proliferative diseases.
  • Shiozawa Akira (Omiya JPX) Inubushi Atsuro (Tokyo JPX) Narita Kazuhisa (Ageo JPX) Sagawa Yukihiro (Yono JPX) Hosono Makoto (Kitamoto JPX) Iida Masashi (Kitamoto JPX), Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases o.
  • Flanagan Richard J. (Hudson CAX) Charleson F. Peter (Kirkland CAX), Chelate derivatives of atrial natriuretic factor (ANF).
  • Postlethwaite Arnold E. ; Seyer Jerome ; Kang Andrew, Chemotactic wound healing peptides.
  • Franckowiak Gerhard (Wuppertal DEX) Stoltefuss Jrgen (Haan DEX) Bechem Martin (Wuppertal DEX) Gross Rainer (Wuppertal DEX) Kayser Michael (Leverkusen DEX) Hebisch Siegbert (Oberhausen DEX) Schramm Ma, Circulation-active fluoromethoxyphenyl dihydropyridine compounds.
  • Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Webb Nancy (College Station TX), Cloning and expression of transforming growth factor b 상세보기
  • Nikolaychik Victor (Mequon WI) Kipshidze Nicholas N. (Bayside WI) Baker John E. (Wauwatosa WI), Coating intraluminal stents.
  • Neumann Friedmund (Berlin DEX), Combined antiestrogens and antigonadotropically effective antiandrogens for the prophylaxis and therapy of hyperplasia o.
  • Boettcher Barry (12 Mahogany Dr. New Lambton ; N.S.W. AUX) Walker William R. (36 Stanley St. Merewether ; N.S.W. AUX) Whitehouse Michael W. (Dept. of Experimental Pathology ; Australian National Univ, Complexes of bivalent copper.
  • Wagner Helmar R. (Darmstadt-Arheilgen DEX), Composition for oral hygiene.
  • Bockow Barry I. (16122-8th Ave. S.W. ; Ste. D3 Seattle WA 98166) Erlitz Marc D. (12034 NE. 130th La. #101 Kirkland WA 98034), Compositions and methods for inhibiting inflammation and adhesion formation.
  • Mantelle Juan A. (Miami FL), Compositions and methods for topical administration of pharmaceutically active agents.
  • Mantelle Juan A. (Miami FL), Compositions and methods for topical administration of pharmaceutically active agents.
  • Mantelle Juan A. (Miami FL), Compositions and methods for topical administration of pharmaceutically active agents.
  • Sporn Michael B. ; Roberts Anita B., Compositions of transforming growth factor .beta.(TGF-.beta.) which promotes wound healing and methods for their use.
  • Gerwick William H. (Corvallis OR) Proteau Philip J. (Corvallis OR) Nagle Dale G. (Corvallis OR), Compound exhibiting antiproliferative activity against cells.
  • Casagrande Cesare (Arese ITX) Montanari Stefania (Milan ITX) Santangelo Francesco (Milan ITX), Compounds active on the cardiovascular system.
  • Dowd Patrick F. (Peoria IL) Cole Richard J. (Albany GA) Vesonder Ronald F. (Peoria IL), Control of insects by fungal tremorgenic mycotoxins.
  • Eppstein Deborah A. (Palo Alto CA) Schryver Brian B. (Redwood City CA), Controlled release of macromolecular polypeptides.
  • Sorenson John R. J. (Little Rock AR) Oberley Larry W. (Iowa City IA), Copper complex for treating cancer.
  • Abdel-Monem Mahmoud M. (Moscow ID) Anderson Michael D. (Minnetonka MN), Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements.
  • Abdel-Monem Mahmoud M. (Moscow ID) Anderson Michael D. (Minnetonka MN), Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements.
  • Anderson Michael D. (Minnetonka MN), Copper complexes with alpha hydroxy organic acids and their use as nutritional supplements.
  • Abrams Michael J. (Glenmore PA) Fontaine Bradley (Landsdowne PA) Giandomenico Christen M. (Exton PA), Copper radiosensitizers.
  • Yamaguchi Shoji (Yokkaichi JPX) Yamada Kimiko (Nagoya JPX), Copper-type conductive coating composition.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as anti-estrogenic, anti-tumor and female fertility agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK), Cyclopropyl analogs as estrogenic and anti-fertility agents.
  • Ruoslahti Erkki I. ; Pierschbacher Michael D. ; Cardenas Jose ; Craig William ; Mullen Daniel G., Decorin fragments inhibiting cell regulatory factors.
  • Fildes Francis J. T. (Macclesfield GB2) Hutchinson Francis G. (Macclesfield GB2), Delivery means for biologically active agents.
  • Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julianne (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
  • Harpel Peter C. (New York NY), Detecting and distinguishing between plasminogen activators.
  • Just Hansjrg (Kreuzkopfsteige 11 D-7800 Freiburg DEX) Solzbach Ulrich (Spechtweg 15 D-7800 Freiburg DEX), Dilatation catheter.
  • Hendrickson Dennis L. (Overland Park KS) Dimmitt Dan C. (Belton MO) Williams Mark S. (Kansas City MO) Skultety Paul F. (Leawood KS) Baltezor Michael J. (Lees Summit MO), Diltiazem formulation.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Overacre Lynette (Norman OK), Diphenylcyclopropyl analogs.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Overacre Lynette (Norman OK), Diphenylcyclopropyl analogs.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Avor Kwasi S. (Columbia MO), Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents.
  • Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Hildebrand Keith R. (Houlton WI), Drug delivery apparatus and method.
  • Choi ; Nam Sok ; Heller ; Jorge, Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates).
  • Wallace Sidney (Houston TX) Yang David (Sugarland TX) Wallace Michael (Houston TX), Efficient microcapsule preparation and method of use.
  • Kaufman Robert J. (University City MO) Richard Thomas J. (University City MO), Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use.
  • Morgan ; Jr. Alton C. (Edmonds WA) Woodhouse Clive S. (Seattle WA) McIntyre Robert F. (Seattle WA), Enhanced production of antibodies utilizing insolubilized immune complexes.
  • Thompson David D. (Gales Ferry CT), Estrogen agonists as remedies for prostate and cardiovascular diseases.
  • Sabel Bernhard A. (Kreuzberg 6 8011 Egmating MA DEX) Freese Andrew (115 Whitcomb Ave. Jamaica Plain MA 02130), Extended drug delivery of small, water-soluble molecules.
  • Hamlin Robert N. (Stillwater MN) Shockey Rick L. (Eagan MN) Tassel Robert A. V. (Excelsior MN), Fiber tip atherectomy catheter.
  • Yamagata Hiroshi (11-806 Toyama JPX) Yamaguchi Tadashi (11-806 Sendai JPX) Takeda Hideki (11-806 Kawasaki JPX) Nishiyama Nobuyuki (11-806 Tokyo JPX) Nozaki Katsutoshi (11-806 Wako JPX) Inoue Akihisa , Hard film of amorphous Ti-Si alloy having fine tin particles.
  • Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Heparin fragments as inhibitors of smooth muscle cell proliferation.
  • Toothman Penelope J. ; Ringquist Steven ; Gold Larry, High affinity TGF.beta. nucleic acid ligands.
  • Toothman Penelope J. ; Ringquist Steven ; Gold Larry, High affinity TGF.beta. nucleic acid ligands and inhibitors.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity halogenated-tamoxifen derivatives and uses thereof.
  • Yang David J. (Sugarland TX) Wallace Sidney (Houston TX), High affinity tamoxifen derivatives and uses thereof.
  • Ito Ralph K. (Quincy MA) LoGerfo Frank W. (Belmont MA), Hirudin-coated biocompatible substance.
  • Cullinan George J. (Trafalgar IN) Yen Terence T. (Indianapolis IN), Hypoglycemic agents.
  • Shepherd, Robert G., Hypolipidemic and antiatherosclerotic novel (monosubstituted-amino)heteroaryl carboxylic acids and analogs.
  • Sonnenschein Carlos (Boston MA) Soto Ana M. (Boston MA), In-vitro methods for identifying compositions which are agonists and antagonists of estrogens.
  • Kleinschroth Jrgen (Denzlingen DEX) Hartenstein Johannes (Stegen-Wittental DEX) Schchtele Christoph (Freiburg DEX) Rudolph Claus (Vrstetten DEX), Indolocarbazoles and the use thereof.
  • Dzau Victor J., Inhibition of proliferation of vascular smooth muscle cell.
  • Clarke Richard H. (Scituate MA), Inhibition of restenosis by ultraviolet radiation.
  • Deckelbaum Lawrence I. (Woodbridge CT) Gasparro Francis P. (Hamden CT) Sumpio Bauer K. (New Haven CT), Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light.
  • Kodama Kazuhisa (Takarazuka JPX) Hirayama Atsushi (Osaka JPX) Masayasu Hiroyuki (Tokyo JPX), Inhibitor for restenosis after percutaneous coronary arterioplasty.
  • Clader John W. (Cranford NJ) Davis Harry R. (Berkeley Heights NJ) Mullins Deborra (New York NY) Rosenblum Stuart (West Orange NJ) Weinstein Jay (Upper Montclair NJ), Inhibitors of platelet-derived growth factor.
  • Fischell Robert E. (14600 Viburnum Dr. Dayton MD 21036) Fischell Tim A. (1018 Chancery La. Nashville TN 37215) Fischell David R. (71 Riverlawn Dr. Fair Haven NJ 07704), Integrated catheter system for balloon angioplasty and stent delivery.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Intra-arterial stent with the capability to inhibit intimal hyperplasia.
  • Shockey Rick L. (Eagan MN) Van Tassel Robert A. (Excelsior MN), Intravascular drug delivery dilatation catheter.
  • Tuch Ronald J., Intravasoular stent and method.
  • McCague Raymond (Reigate GB2), Iodotamoxifen derivatives and use for estrogen receptor-positive breast cancer detection and therapy.
  • Ichijo Hidenori,SEX ; Miyazono Kohei,SEX ; Ronnstrand Lars,SEX ; Hellman Ulf,SEX ; Wernstedt Christer,SEX ; Heldin Carl-Henrik,SEX, Isolated nucleic acid encoding receptor-like TGF-.beta.1 binding protein.
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Miyazono Kohei (Uppsala SEX) Heldin Carl-Henrik (Uppsala SEX) Olofsson Anders (Uppsala SEX), Isolated, large latent complexes of TGF-bb 상세보기
  • Kauffman Raymond F. (11420 Saint Andrews La. Carmel IN 46032) Singh Jai P. (13774 Hill Crest Ct. Carmel IN 46032), Local delivery of dipyridamole for the treatment of proliferative diseases.
  • Desai Neil P. (Los Angeles CA) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Grinstaff Mark W. (Pasadena CA) Suslick Kenneth S. (Champaign IL), Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell.
  • Charmot Dominique (Paris FRX) Vidil Christine (Paris FRX), Magnetizable composite microspheres of hydrophobic crosslinked polymer, process for preparing them and their application.
  • Benita Simon (Jerusalem ILX) Levy Menashe (Jerusalem ILX), Medicinal emulsions.
  • Fritzberg Alan R. (Edmonds WA) Kasina Sudhakar (Kirkland WA) Srinivasan Ananthachari (Kirkland WA) Wilbur Daniel S. (Edmonds WA), Metal radionuclide labeled proteins for diagnosis and therapy.
  • Reichert Paul (Montville NJ) McNemar Charles (Basking Ridge NJ) Nagabhushan Nagamani (Parsippany NJ) Nagabhushan Tattanahalli L. (Parsippany NJ) Tindall Stephen (Madison NJ) Hruza Alan (Hackettstown , Metal-interferon-alpha crystals.
  • Slepian Marvin J. (Cleveland Heights OH), Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens.
  • Pollack Robert L. (8442 Chippewa Rd. Philadelphia PA 19128), Method and composition for increasing production of serotonin.
  • Mnsson Per (Sollentuna SEX) Rolfsen Wenche (Upsala SEX) Wickstrom Kerstin (Upsala SEX), Method and means for inhibiting posterior capsule opacification.
  • Spears J. Richard (Winchester MA) Bourgelais Donna (Malden MA), Method for angioplasty.
  • Tuch Ronald J., Method for delivering a therapeutic substance to a body lumen.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN), Method for delivery of smooth muscle cell inhibitors.
  • Spears J. Richard (Boston MA), Method for diagnosis of atherosclerosis.
  • Crissman Harry A. (Los Alamos NM) Gadbois Donna M. (Los Alamos NM) Tobey Robert A. (Los Alamos NM) Bradbury E. Morton (Santa Fe NM), Method for distinguishing normal and transformed cells using G1 kinase inhibitors.
  • Grainger David J. (Cambridge GB2) Metcalfe James C. (Cambridge GB2), Method for identifying an agent which increases TGF-beta levels.
  • Sales James J. (Indianapolis IN), Method for increasing libido in post-menopausal women.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B]thien-3-yl-4-[2-(piperidin-1-yl)ethoxyphenyl.
  • Williams Daniel C. (Fishers IN), Method for inhibiting cartilage degradation.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Method for lowering serum cholesterol.
  • Fontana Steven A. (Martinsville IN), Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives.
  • Iwata Kenneth K. (Westbury NY) Foulkes J. Gordon (Huntington NY) Dijke Peter T. (Port Washington NY) Haley John D. (Great Neck NY), Method for obtaining bone marrow free of tumor cells using transforming growth factor b 상세보기
  • Yamashita Nobuhiko (Takatsuki JPX), Method for preparing peptides and proteins utilizing ribosome.
  • Ondetti Miguel A. (Princeton NJ) Aberg A. K. Gunnar (Lawrenceville NJ) Ferrer Patricia (Pennington NJ), Method for preventing onset of restenosis after angioplasty employing an ace inhibitor.
  • McGovern Mark E. (Philadelphia PA) Ondetti Miguel A. (Princeton NJ) Pan Henry Y. (Princeton Junction NJ), Method for preventing onset of restenosis after angioplasty employing pravastatin.
  • March Keith L. (Carmel IN) Hathaway David R. (Indianapolis IN) Wilensky Robert L. (Indianapolis IN) Patton Brian L. (Thorntown IN), Method for preventing restenosis following reconfiguration of body vessels.
  • Sauvage Lester R. (Seattle WA) Kaplan Svetlana (Mountlake Terrace WA) Kaplan Alexander (Mountlake Terrace WA), Method for reducing platelet aggregation.
  • Yang Na N. (Indianapolis IN), Method for screening anti-osteoporosis agents.
  • Foker John E. (Minneapolis MN), Method for stimulating recovery from ischemia employing ribose and adenine.
  • Tamai Hideo (Moriyama JPX) Ueda Kinzo (Kusatsu JPX) Hsu Yung-sheng (Moriyama JPX), Method for the inhibition of restenosis associated with coronary intervention.
  • Wolinsky Harvey (175 Riverside Dr. New York NY 10024), Method for the prevention of restenosis.
  • Sorenson John R. J. (Little Rock AR), Method for treating convulsions and epilepsy with organic copper compounds.
  • Sorenson John R. J. (Little Rock AR), Method for treating convulsions and epilepsy with organic copper compounds.
  • Sorenson John R. J. (Little Rock AR), Method for treating convulsions and epilepsy with organic copper compounds.
  • Sorenson John R. J. (Little Rock AR), Method for treating convulsions and epilepsy with organic copper compounds.
  • Stolle Ralph J. (Oregonia OH) Beck Lee R. (Birmingham AL), Method for treating disorders of the vascular and pulmonary systems.
  • Leeds James P. (Noblesville IN), Method for treating smoking-related bone loss.
  • Hupe Donald (Ann Arbor MI) Keiser Joan A. (Ann Arbor MI), Method for treating vascular proliferative disorders following balloon angioplasty.
  • Greenwald James E. (St. Louis MO), Method for treatment of arterial stenosis.
  • May Patrick C. (Carmel IN), Method of inhibiting Alzheimer\s Disease.
  • Fischbarg Jorge (New York NY) Liebovitch Larry S. (Long Island City NY) Koniarek Jan P. (Briarcliff Manor NY), Method of inhibiting osmotic water flow.
  • Harker Laurence A. (San Diego CA) Hanson Stephen R. (Encinitas CA), Method of inhibiting platelet dependent arterial thrombosis.
  • Cullinan George J. (Trafalgar IN), Method of inhibiting seborrhea and acne.
  • Amento Edward P. (Portola Valley CA) Beck L. Steven (Los Altos CA), Method of predisposing mammals to accelerated tissue repair.
  • Trojanowski John Q. (Philadelphia PA) Lee Virginia M-Y. (Philadelphia PA), Method of stabilizing microtubules.
  • Kinsella James L. (Baltimore MD) Sollott Steven J. (Baltimore MD), Method of treating atherosclerosis or restenosis using microtubule stabilizing agent.
  • Gregory Clare R. (Davis CA) Morris Randall E. (Los Altos CA), Method of treating hyperproliferative vascular disease.
  • Mitchell Robert D. (Doylestown PA) Skwish Stephen (Mercer NJ), Method of treating hyperproliferative vascular disease.
  • Morris Randall E. (Los Altos CA) Gregory Clare R. (Menlo Park CA), Method of treating hyperproliferative vascular disease.
  • Morris Randall E. (Stanford CA) Bartlett Robert R. (Darmstadt DEX), Method of treating hyperproliferative vascular disease.
  • Morris Randall Ellis (Los Altos CA) Gregory Clare Robert (Menlo Park CA), Method of treating hyperproliferative vascular disease.
  • Morris Randall Ellis (Los Altos CA) Gregory Clare Robert (Menlo Park CA), Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid.
  • Glaser Bert M. ; Pharriss ; deceased Bruce B. ; Hanham Ann F. ; Ksander George A., Method of treating ophthalmic disorders using TGF -.beta..
  • Stromberg Brent V. (511 Corley Dr. Chesterfield MO 63017), Method of treating peripheral vasoconstriction with tamoxifen citrate.
  • Morris Randall E. (Los Altos CA) Gregory Clare R. (Menlo Park CA), Method of treating restenosis with rapamycin.
  • Spears James R. (Boston MA), Method of treatment of atherosclerosis and a balloon catheter for same.
  • Scheinberg Israel H. (5447 Palisades Ave. Bronx NY 10471), Method of treatment of rheumatoid arthritis.
  • Scheinberg Israel H. (5447 Palisades Ave. Bronx NY 10471), Method of treatment of rheumatoid arthritis.
  • Pickart Loren R. (Bellevue WA), Methods and compositions for healing ulcers.
  • Pickart Loren R. (Bellevue WA), Methods and compositions for healing ulcers.
  • Daddona Peter E. (West Chester PA) Berger Harvey J. (Devon PA) McEver Rodger P. (Oklahoma City OK), Methods for imaging atherosclerotic plaque.
  • Singh Jai P. (Carmel IN), Methods for inhibiting angiogenesis.
  • Fontana Steven A. (Martinsville IN), Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Methods for inhibiting bone loss.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Methods for inhibiting bone loss by treating with aroylbenzothiophenes and estrogen.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for inhibiting bone loss using substituted benzothiophene.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Draper Michael W. (Carmel IN) Jones Charles D. (Indianapolis IN) Seyler David E. (Greenfield IN), Methods for inhibiting endometriosis.
  • Fontana Steven A. (Martinsville IN), Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for inhibiting uterine fibrosis.
  • Singh Jai P. (Carmel IN) Wiernicki Todd R. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell migration.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Cullinan George J. (Trafalgar IN) Singh Jai P. (Carmel IN) Wood Dan L. (Indianapolis IN), Methods for inhibiting vascular smooth muscle cell proliferation and restinosis.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for lowering serum cholesterol.
  • Bryant Henry U. (Indianapolis IN) Grese Timothy A. (Indianapolis IN), Methods for lowering serum cholesterol.
  • Bryant Henry U. (Indianapolis IN) Dodge Jeffrey A. (Indianapolis IN), Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and u.
  • Labroo Virender M. (Mill Creek WA) Piggott James R. (Bothell WA) Bain Steven D. (Seattle WA), Methods for reducing bone loss using centchroman derivatives.
  • Cullinan George J. (Trafalgar IN) Termine John D. (Indianapolis IN), Methods for the treatment of peri-menopausal syndrome.
  • May Patrick C. (Carmel IN), Methods of inhibiting Alzheimer\s Disease.
  • May Patrick C. (Carmel IN), Methods of inhibiting Alzheimer\s disease.
  • Dodge Jeffrey A. (Indianapolis IN), Methods of inhibiting Turner\s syndrome.
  • Cullinan George J. (Trafalgar IN), Methods of inhibiting atrophy of the skin and vagina.
  • Zuckerman Steven H. (Indianapolis IN), Methods of inhibiting autoimmune diseases.
  • Grinnell Brian W. (Indianapolis IN), Methods of inhibiting cell-cell adhesion.
  • Grinnell Brian W. (Indianapolis IN), Methods of inhibiting cell-cell adhesion.
  • Glasebrook Andrew L. (Zionsville IN), Methods of inhibiting demyelinating and desmyelinating diseases.
  • Keohane Patrick (Indianapolis IN), Methods of inhibiting dysfunctional uterine bleeding.
  • Jones Charles D. (Indianapolis IN) Tinsley Frank C. (Indianapolis IN), Methods of inhibiting fertility in women.
  • Bumol Thomas F. (Carmel IN) Cullinan George J. (Trafalgar IN), Methods of inhibiting imperfect tissue repair.
  • Bumol Thomas F. (Carmel IN) Cullinan George J. (Trafalgar IN), Methods of inhibiting imperfect tissue repair.
  • Dodge Jeffrey A. (Indianapolis IN), Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism.
  • Zuckerman Steven H. (Indianapolis IN), Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes.
  • Dodge Jeffrey A. (Indianapolis IN), Methods of inhibiting sexual precocity.
  • Fontana Steven A. (Martinsville IN), Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder.
  • Sall Daniel J. (Greenwood IN) Smith Gerald F. (Indianapolis IN), Methods of inhibiting thrombin.
  • Sall Daniel J. (Greenwood IN) Smith Gerald F. (Indianapolis IN), Methods of inhibiting thrombin.
  • Sall Daniel J. (Greenwood IN) Smith Gerald F. (Indianapolis IN), Methods of inhibiting thrombin.
  • Cullinan George J. (Trafalgar IN), Methods of inhibiting ulcerative mucositis.
  • Black Larry J. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Draper Michael W. (Carmel IN) Jones Charles D. (Indianapolis IN) Seyler David E. (Greenfield IN), Methods of inhibiting uterine fibrosis.
  • Dodge Jeffrey A. (Indianapolis IN) Sato Masahiko (Carmel IN), Methods of inhibiting vascular restenosis.
  • Haley John D. (Great Neck NY), Methods of prevention of oral mucositis with transforming growth factor b 상세보기
  • Schreiber Alan D. (Philadelphia PA), Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc recepto.
  • Fontana Steven A. (Martinsville IN), Methods of treating menstrual symptoms and compositions therefore.
  • Draper Michael W. (Carmel IN), Methods of use for inhibiting bone loss and lowering serum cholesterol.
  • Draper Michael W. (Carmel IN), Methods of use for inhibiting bone loss and lowering serum cholesterol.
  • Draper Michael W. (Carmel IN), Methods of use for inhibiting bone loss and lowering serum cholesterol.
  • Purchio Anthony F. (Seattle WA) Madisen Linda (Seattle WA) Merwin June R. (Clinton CT), Methods using novel chimeric transforming growth factor-bb 상세보기
  • Scher Herbert B. (Moraga CA) Rodson Marius (El Cerrito CA), Microcapsules.
  • Wolf Peter A. (100 Stevens Ave. Valhalla NY 10595) Havekotte Margaret J. (74 Byram Terrace Dr. Greenwich CT 06830), Microemulsions of oil in water and alcohol.
  • Lee Haibang (Daejun-si KRX) Yuk Soonhong (Daejun-si KRX), Microencapsulation for controlled oral drug delivery system.
  • Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  • Tice Thomas R. (Helena AL) Lewis Danny H. (Gardendale AL), Microencapsulation process.
  • Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL), Microencapsulation process and products therefrom.
  • Steward Frederick A. (Pittsburgh PA), Micronutrient supplement.
  • Vidal Juan C. (Boston MA), Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent.
  • Dasch James R. (Palo Alto CA) Pace ; III Doran R. (San Francisco CA) Waegell Wendy O. (Mountain View CA), Monoclonal antibodies which bind both transforming growth factors bb<.
  • Prather Randall S. (Madison WI) Barnes Frank (Madison WI) Robl James (Belchertown MA) First Neal L. (Madison WI) Simmon Vincent F. (Potomac MD), Multiplying bovine embryos.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN) Lugar Charles W. (McCordsvi, Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN) Lugar Charles W. (McCordsvi, Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell prolifera.
  • Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN) Dodge Jeffrey A. (Indianapolis IN) Fahey Kennan J. (Indianapolis IN) Jones Charles D. (Indianapolis IN) Lugar Charles W. (McCordsvi, Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis.
  • Conrad H. Edward (Alameda CA) Guo Yuchuan (Alameda CA), Non-anticoagulant heparin derivatives.
  • Gitter Bruce D. (Carmel IN) Lunn William H. W. (Indianapolis IN), Non-peptide tachykinin receptor antagonists to treat allergy.
  • Gitter Bruce D. (Carmel IN) Lunn William H. W. (Indianapolis IN), Non-peptide tachykinin receptor antagonists to treat psycological disorder.
  • Willson Timothy Mark (Durham NC), Non-steroidal ligands for the estrogen receptor.
  • Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Purchio Anthony F. (Seattle WA), Normal human growth regulatory receptor for TGF-b 상세보기
  • Confalone Pasquale N. (West Caldwell NJ) Pizzolato Giacomo (Glen Ridge NJ) Uskokovic Milan R. (Upper Montclair NJ) Rouge Marianne (Basel CHX), Novel thiophene derivatives.
  • Confalone Pasquale N. (West Caldwell NJ) Pizzolato Giacomo (Glen Ridge NJ) Uskokovic Milan R. (Upper Montclair NJ) Rouge Marianne (Basel CHX), Novel thiophene derivatives.
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turki FIX) Blanco Guillermo L. (Oulu FIX) Sunduiqst Hann, Novel tri-phenyl alkane and alkene derivatives and their preparation and use.
  • McGrath James (Philadelphia PA) Solter Davor (Philadelphia PA), Nuclear transplantation in the mammalian embryo by microsurgery and cell fusion.
  • Derynck Rik M. A. (So. San Francisco CA) Goeddel David V. (Hillsborough CA), Nucleic acid encoding TGF-b 상세보기
  • Derynk Rik M. A. (So. San Francisco CA) Goeddel David V. (Forestview CA), Nucleic acid encoding TGF-b 상세보기
  • Donahoe Patricia K. (Weston MA) Gustafson Michael (Boston MA) He Wei-Wu (Columbia MD) Wang Xiao-Fan (Durham NC), Nucleic acids encoding a TGF-b 상세보기
  • Marquardt Hans (Mercer Island WA) Zarling Joyce M. (Seattle WA) Shoyab Mohammed (Seattle WA) Hanson Marcia B. (Seattle WA) Lioubin Mario N. (Bellevue WA) Brown Thomas J. (Seattle WA) Ikeda Tatsuhiko , Oncostatin M and novel compositions having anti-neoplastic activity.
  • Sorenson John R. J. (Little Rock AR), Organic copper complexes as radioprotectants.
  • Fretto Larry J. (Sausalito CA), PDGF receptor blocking peptides.
  • Hock Janet M. (Indianapolis IN), Parathyroid hormone and raloxifene for increasing bone mass.
  • Grese Timothy Alan, Pentacyclic compounds, intermediates, processes, compositions, and methods.
  • Shlyankevich Mark (Waterbury CT), Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis.
  • Breccia Alberto (Bologna ITX) Fini Adamo (Bologna ITX), Pharmaceutical compositions containing thiophene compounds, and new thiophene compounds.
  • Draper Michael W., Pharmaceutical unit dosage formulations.
  • Demopoulos Harry B. (Scarsdale NY), Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis fol.
  • Bisaccia Emil (4 Sunnybrook Rd. Basking Ridge NJ 07920) Klainer Albert S. (315 W. 70th St. New York NY 10023), Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty.
  • Matsuda, Yuzuru; Iwahashi, Kazuyuki; Iida, Takao; Hirayama, Noriaki; Asano, Kozo; Shuto, Katsuichi; Yamada, Koji; Shirahata, Kunikatsu; Kase, Hiroshi, Physiologically active substance K-252, process for producing same and pharmaceutical composition containing same.
  • Novak Sarah T. A. (Cary NC) Soll Richard M. (Lawrenceville NJ) Ellingboe John W. (Princeton NJ) Nguyen Thomas T. (Philadelphia PA), Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation.
  • Grinstaff Mark W. (Pasadena CA) Desai Neil P. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Merideth Noma R. (Pacific Palis, Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof.
  • Racchini Joel R. (Edina MN) Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Hildebrand Keith R. (Houlton WI), Porous balloon for selective dilatation and drug delivery.
  • Stossel Thomas P. (Belmont MA) Hartwig John H. (Jamaica Plain MA) Janmey Paul A. (Arlington MA), Preservation of blood platelets.
  • Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GB2, Prevention and treatment of cardiovascular pathologies.
  • Grainger David J. (Cambridge GB2) Metcalfe James C. (Cambridge GB2) Weissberg Peter L. (Cambridge GB2), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J. (Cambridge GBX) Metcalfe James C. (Cambridge GBX) Weissberg Peter L. (Cambridge GBX), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J. (Cambridge GBX) Metcalfe James C. (Cambridge GBX) Weissberg Peter L. (Cambridge GBX), Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX, Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells.
  • Cianciolo George J. (San Carlos CA), Process for making biologically active polypeptides based on transforming growth factor-b 상세보기
  • Briggs Barbara S. (Indianapolis IN) Zmijewski ; Jr. Milton J. (Carmel IN), Process for preparation of benzo[B]thiophene glucuronides.
  • Bindschaedler Christian (4 route de Malagny CH 1294 Genthold CHX) Gurny Robert (7 rue Calvin CH 1204 Geneva CHX) Doelker Eric (24 avenue Dumas CH 1206 Geneva CHX), Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powd.
  • Platz Robert M. (Half Moon Bay CA) Ip Anna (Moorpark CA) Whitham Clyde L. (Montara CA), Process for preparing micronized polypeptide drugs.
  • O\Toole Michael P. (Norwalk CT), Process for producing small polymer phase droplet microemulsions by multistep aqueous phase addition.
  • Murakata Chikara (Hachioji JPX) Takiguchi Toshimitsu (Gotenba JPX) Katsumata Shigeo (Mishima JPX) Mihara Akira (Machida JPX) Takahashi Keiichi (Susono JPX) Saito Hiromitsu (Mishima JPX) Akinaga Shiro, Process for producing staurosporine derivatives.
  • Jungfer Herbert (Tutzing DEX) Barchet Heinrich (Tutzing DEX) Albert Winfried (Phl DEX), Process for the production of permanently culturable animal and human cell lines and the use thereof.
  • Christen Alice A. (Metairie LA) Gibson Donna M. (New Orleans LA) Bland John (Kenner LA), Production of taxol or taxol-like compounds in cell culture.
  • Sporn Michael B. (Bethesda MD) Roberts Anita B. (Bethesda MD), Promotion of cell proliferation by use of transforming growth factor beta (TGF-b 상세보기
  • Burch Ronald M. (Silver Spring MD) Patch Raymond J. (Baltimore MD) Shearer Barry G. (Baltimore MD) Perumattam John J. (Baltimore MD), Protein kinase C modulators.
  • Dake Michael D. (1915 Mandeville Canyon Rd. Los Angeles CA 90049) Hedger Bruce (16220 Gundry Ave. Paramount CA 90723) Oesterle Stephen (101 Burlingame Ave. Los Angeles CA 90049), Radioactive catheter.
  • Cox Edward T. (Foster City CA) Mather Jennie P. (Millbrae CA) Sliwkowski Mary B. (San Carlos CA) Woodruff Teresa K. (Millbrae CA), Receptor polypeptides and their production and uses.
  • Seifter Eli (New Hyde Park NY) Rettura Giuseppe (Bronx NY), Reduction of high dose aspirin toxicity by dietary vitamin A.
  • Dror Michael (Edina MN) Trescony Paul (Robbinsdale MN), Releasable coatings on balloon catheters.
  • Niikura Kazuaki (Ibaraki JPX) Nakajima Yoshimitsu (Ibaraki JPX) Notsu Yoshitada (Ibaraki JPX) Ono Ryuji (Ibaraki JPX) Nakayama Osamu (Ibaraki JPX), Remedies for bone diseases.
  • Wheeler Jeffery J. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX), Stable microemulsions for hydrophobic compound delivery.
  • Grafe Ingomar (Nuremberg DEX) Schickaneder Helmut (Eckental DEX) Jungblut Peter W. (Hanover DEX) Ahrens Kurt H. (Nuremberg DEX), Stable solvent adducts of Z-1-(p-b 상세보기
  • Caravatti Giorgio (Allschwil CHX) Fredenhagen Andreas (Basel CHX), Staurosporine derivatives substituted at methylamino nitrogen.
  • Williams Michael S. (Cupertino CA), Stent capable of attachment within a body lumen.
  • Ichijo Hidenori (Upsala SEX) Miyazono Kohei (Upsala SEX) Ronnstrand Lars (Upsala SEX) Hellman Ulf (Upsala SEX) Wernstedt Christer (Upsala SEX) Heldin Carl-Hendrik (Upsala SEX), Substantially pure receptor like TFG-b 상세보기
  • Ichijo Hidenori (Upsala SEX) Miyazono Kohei (Upsala SEX) Rnnstrand Lars (Upsala SEX) Hellman Ulf (Upsala SEX) Wernstedt Christer (Upsala SEX) Heldin Carl-Henrik (Upsala SEX), Substantially pure receptor like TGF-b 상세보기
  • Conrad H. Edward (Alameda CA) Fugedi Peter (Alameda CA) Brandley Brian K. (Alameda CA) Lam Lun H. (Cupertino CA) Laine Roger A. (Alameda CA), Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation.
  • Black Larry J. (Indianapolis IN) Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Sulfonate derivatives of 3-aroylbenzo[b]thiophenes.
  • Liversidge Gary G. (West Chester PA) Cundy Kenneth C. (Pottstown PA) Bishop John F. (Rochester NY) Czekai David A. (Honeoye Falls NY), Surface modified drug nanoparticles.
  • Peters, Mary K., Synthesis of acylated benzothiophenes.
  • Purchio Anthony F. (Seattle WA) Skonier John E. (Seattle WA) Neubauer Michael G. (Seattle WA), TGF-b 상세보기
  • Brown Dennis M. (Menlo Park CA) Luck Edward (Menlo Park CA) Twardzik Daniel R. (Bainbridge Island WA) Purchio Anthony F. (Seattle WA), TGF-b 상세보기
  • Srinivasan Ananthachari (Kirkland WA) Brixner Diana I. (Lynnwood WA) Vrudhula Vivekananda M. (Edmonds WA), Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages.
  • Labrie Fernand (Quebec CAX) Merand Yves (Quebec CAX), Therapeutic antiestrogens.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2 ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  • Abiuso Christopher L. (Miami FL) Leone James E. (Miami FL), Therapeutic porous balloon catheter.
  • Stossel Thomas P. (Belmont MA) Lind Stuart E. (Belmont MA) Janmey Paul A. (Belmont MA), Therapeutic uses of actin-binding compounds.
  • Yoshida Risaburo (Tokyo JPX) Kaiho Keisuke (Tokyo JPX) Ide Yusaku (Tokyo JPX) Noda Kanji (Chikushino JPX) Yamagata Tetsuya (Tosu JPX) Kida Hirotaka (Fukuoka JPX), Thermogenic sheet-combined poultices.
  • Pettit John W. (Derwood MD), Thickness/density mesuring apparatus.
  • Baldus Berthold (Berlin DEX) Maass Bernhard (Berlin DEX) Mller Bernd (Berlin DEX) Witt Werner (Berlin DEX), Thrombosis treatment with fibrinolytics and prostacyclins.
  • Bell Eugene (Dedham MA), Tissue-equivalent and method for preparation thereof.
  • Raaf Helmut (Bad Schwalbach DEX) Becker Dieter (Darmstadt-Wixhausen DEX) Frosch Franz (Taunusstein DEX) Harth Helmt (Mainz DEX) Wgner Helmar R. (Darmstadt DEX), Toothpaste active against plaque comprising a copper compound and a plastic polishing agent.
  • Raaf Helmut (Bad Schwalbach DEX) Becker Dieter (Darmstadt-Wixhausen DEX) Frosch Franz (Taunusstein DEX) Harth Helmut (Mainz DEX) Wagner Helmar R. (Darmstadt DEX), Toothpaste active against plaque comprising a copper compound and a silica polishing agent.
  • DeGregorio Michael W. (Granite Bay CA) Kurkela Kauko O. A. (Espoo FIX), Topical administration of toremifene and its metabolites.
  • Proctor Peter H. (Twelve Oaks Medical Tower 4126 SW. Freeway ; Suite 1616 Houston TX 77027), Topical sod for treating hair loss.
  • Ogawa Yasushi (Pacifica CA) Schmidt David (Santa Cruz CA) Dasch James (Palo Alto CA), Transforming growth factor b 상세보기
  • Ishiguro Keiji (Narashino JPX) Uotani Osamu (Chiba JPX) Seyama Minako (Tokyo JPX), Transparent liquid oral composition.
  • Ohlstein Eliot H. (Glenmoore PA), Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds.
  • Leveen Harry H. (321 Confederate Cir. Charleston SC 29407) Leveen Robert F. (312 Lombard St. Philadelphia PA 19147) Leveen Eric G. (141 S. Battery Charleston SC 29401), Treatment of cancer with phlorizin and its derivatives.
  • Trager Seymour F. (14 Sherwood Dr. Plainview NY 11803) Blackburn G. Michael (23 Crimicar La. Sheffield ; S10 4FA GBX), Treatment of glaucoma.
  • Casscells Ward M. (La Jolla CA) Lappi Douglas A. (Del Mar CA) Baird J. Andrew (San Diego CA), Treatment of vascular injury.
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turku FIX) Blanco Guillermo L. (Oulu FIX) Sundquist Hann, Tri-phenyl alkane derivatives and their oestrogenic, anti-oestrogenic and progestanic uses.
  • Toivola Reijo J. (Oulu FIX) Karjalainen Arto J. (Oulu FIX) Kurkela Kauko O. A. (Oulu FIX) Soderwall Marja-Liisa (Oulu FIX) Kangas Lauri V. M. (Turku FIX) Blanco Guillermo L. (Oulu FIX) Sundquist Hann, Tri-phenyl alkene derivatives and their preparation and use.
  • Magarian Robert A. (Norman OK) Pento Joseph T. (Norman OK) Day Billy W. (Newtonville MA), Triarylcyclopropanes as antiestrogens and antitumor agents.
  • Ruenitz Peter C. (Clarke City GA), Triarylethylene carboxylic acids with estrogenic activity.
  • Pavanasasivam Gowsala (Edmonds WA), Trichothecene antibody conjugates.
  • Sivam Gowsala (Edmonds WA), Trichothecene conjugates and methods of use.
  • Nakano Hirofumi (Machida JPX) Takahashi Isami (Machida MA JPX) Tamaoki Tatsuya (Brooklin MA) Tomita Fusao (Machida JPX) Kawamoto Isao (Hiratsuka JPX) Asano Kozo (Machida JPX) Morimoto Makoto (Nagaizu, UCN-01 and process for production thereof.
  • Pickart Loren R. (15232 SE. 48th Dr. Bellevue WA 98006), Use of GHL-Cu as a wound-healing and anti-inflammatory agent.
  • Fischell Robert E. (Dayton MD) Fischell Tim A. (Los Altos CA), Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct.
  • Hansson Gran (Dr Linds gata 6 S-413 25 Gteborg SEX) Holm Jan (nggardsplatsen 8 S-413 19 Gteborg SEX) Jonasson Lena (Grna gatan 8 S0575 33Eksj SEX), Use of gamma-interferon for the treatment of vascular stenosis.
  • Na George C. (Fort Washington PA) Rajagopalan Natarajan (Phoenixville PA), Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization.
  • Cronin Michael (San Mateo CA) Osheroff Phyllis L. (Woodside CA) Ward David G. (Oakdale CA), Use of relaxin in cardiovascular therapy.
  • Brahn Ernest (Encino CA), Use of taxol in the treatment of rheumatoid arthritis.
  • Harris Adrian L. (83 Kingston Road Oxford OX2 64J GB3) Kangas Lauri V. M. (Pasantie 3 B 21280 Raisio CT FIX) DeGregorio Michael W. (93 Leatherman Trail Hamden CT 06518), Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs.
  • Ohlstein Eliot H. (Glenmoore PA), Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell pr.
  • Yue Tian-Li (Havertown PA) Ohlstein Eliot H. (Glenmoore PA) Feuerstein Giora Z. (Wynnewood PA), Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and prolifer.
  • Segarini Patricia R. (38 Devonshire Ave. ; #5 Mountain View CA 94043) Dasch James R. (837 Seminole Redwood City CA 94062) Olsen David R. (276 Hedge Rd. Menlo Park CA 94025) Carrillo Pedro A. (1966 Ca, Uses of TGF-b 상세보기
  • Lewis Jerome M. (Newton MA) Menz Edward T. (Quincy MA) Kenny Francis E. (Watertown MA) Groman Ernest V. (Brookline MA) Josephson Lee (Arlington MA), Vascular magnetic resonance imaging agent comprising nanoparticles.
  • 이 특허를 인용한 특허 (116)

    1. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
    2. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
    3. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
    4. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
    5. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Henrich, Georgette, Application of a coating on a medical device.
    6. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Henrich, Georgette, Application of a coating on a medical device.
    7. Herweck, Steve A.; Martakos, Paul; Moodie, Geoffrey; Labrecque, Roger; Karwoski, Theodore; Carlton, Trevor, Application of a therapeutic substance to a tissue location using an expandable medical device.
    8. Morris, Andrew; Schmid, Eric; Sheriff, Jeffrey; Felkins, Brandon, Axially nested slide and lock expandable device.
    9. Schmid, Eric V.; Nguyen, John D.; Padilla, Orlando; Morris, Andrew; Moore, Daniel; Jackson, Thomas R., Axially nested slide and lock expandable device.
    10. Morris, Andrew; Schmid, Eric; Sheriff, Jeffrey T.; Esser, Keith, Axially-radially nested expandable device.
    11. Morris, Andrew; Schmid, Eric; Sheriff, Jeffrey T.; Esser, Keith, Axially-radially nested expandable device.
    12. Morris, Andrew; Sheriff, Jeffrey T.; Esser, Keith, Axially-radially nested expandable device.
    13. Schmid, Eric V.; Morris, Andrew; Nguyen, John; Eisele, Robert F.; Howard, Steven C.; Padilla, Orlando M.; Simpson, Philip J., Balloon expandable crush-recoverable stent device.
    14. Schmid, Eric V.; Morris, Andrew; Nguyen, John; Eisele, Robert F; Howard, Steven C; Padilla, Orlando M; Simpson, Philip J, Balloon expandable crush-recoverable stent device.
    15. Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Barrier layer.
    16. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Barrier layer with underlying medical device and one or more reinforcing support structures.
    17. Laborde, Jean-Claude; Elicker, Robert John; Trauthen, Brett; Seguin, Jacques, Bifurcation stent and method of positioning in a body lumen.
    18. Roth, Noah M.; Kondabatni, Kishore; Karnati, Chandana; Brodbeck, William, Biodegradable device.
    19. Schmid, Eric; Morris, Andrew; Padilla, Orlanda, Circumferentially nested expandable device.
    20. Schmid, Eric; Morris, Andrew; Padilla, Orlando, Circumferentially nested expandable device.
    21. Schmid, Eric; Morris, Andrew; Padilla, Orlando, Circumferentially nested expandable device.
    22. Bates, Brian L.; Ragheb, Anthony O.; Fearnot, Neal E.; Kozma, Thomas G.; Voorhees, III, William D., Coated implantable medical device.
    23. Bates, Brian L.; Boatman, Scott E.; Burton, David G.; Hoffa, Michael C.; Schaeffer, Darin G.; Sturgeon, Jason S.; Ragheb, Anthony O., Coated medical device.
    24. Furst, Joseph G.; Brodbeck, William G., Coated medical device.
    25. Martakos, Paul; Herweck, Steve A.; Prowse, Jocelyn; Horton, Anthony Richard; Faucher, Keith M.; Ferraro, Joseph, Coated surgical mesh.
    26. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph F.; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Coating material and medical device system including same.
    27. Grainger, David J.; Metcalfe, James C.; Kasina, Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    28. Grainger,David J.; Metcalfe,James C.; Kasina,Sudhakar, Compounds and therapies for the prevention of vascular and non-vascular pathologies.
    29. Faucher, Keith M.; Tang, Hui; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
    30. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
    31. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
    32. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Cured gel and method of making.
    33. Faucher, Keith M.; Conroy, Suzanne; Albergo, Theresa K.; Bienkiewicz, Joseph, Cured oil-hydrogel biomaterial compositions for controlled drug delivery.
    34. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
    35. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
    36. Seguin, Jacques; Elicker, Robert John; Laborde, Jean-Claude, Endoprosthesis deployment methods for treating vascular bifurcations.
    37. Seguin, Jacques; Elicker, Robert John; Laborde, Jean-Claude, Endoprosthesis deployment system for treating vascular bifurcations.
    38. Seguin, Jacques; Laborde, Jean-Claude, Endoprosthesis for vascular bifurcation.
    39. Séguin, Jacques; LaBorde, Jean-Claude, Endoprosthesis for vascular bifurcation.
    40. Herweck, Steve A.; Gingras, Peter H.; Martakos, Paul; Karwoski, Theodore, Expandable fluoropolymer device for delivery of therapeutic agents and method of making.
    41. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    42. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    43. Shanley, John F., Expandable medical device for delivery of beneficial agent.
    44. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    45. Shanley, John F.; Eigler, Neal L.; Park, Kinam; Edelman, Elazer R., Expandable medical device for delivery of beneficial agent.
    46. Shanley,John F.; Eigler,Neal L.; Park,Kinam; Edelman,Elazer R., Expandable medical device for delivery of beneficial agent.
    47. Shanley, John F., Expandable medical device with S-shaped bridging elements.
    48. Shanley, John F., Expandable medical device with beneficial agent concentration gradient.
    49. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    50. Shanley, John F., Expandable medical device with beneficial agent delivery mechanism.
    51. Shanley, John F., Expandable medical device with ductile hinges.
    52. Shanley, John F., Expandable medical device with ductile hinges.
    53. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix for intraluminal drug delivery.
    54. Ehrenreich, Kevin J.; Newhauser, Richard R.; von Oepen, Randolf; Stankus, John, Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery.
    55. Von Oepen, Randolf; Stankus, John; Stamberg, Barbara; Yribarren, Travis R.; Newhauser, Richard R., Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery.
    56. Schmid, Eric; Morris, Andrew; Weier, Keith; Bonsignore, Craig; Esser, Keith; Howard, Steven C.; DiPari, Joseph A., Expandable slide and lock stent.
    57. Schmid, Eric; Morris, Andrew; Weier, Keith; Bonsignore, Craig; Esser, Keith; Howard, Steven C.; DiPari, Joseph A., Expandable slide and lock stent.
    58. Schmid, Eric; Weier, Keith; Esser, Keith A.; Howard, Steven C.; Hobson, John; Bonsignore, Craig, Expandable slide and lock stent.
    59. Schmid, Eric; Weier, Keith; Esser, Keith A.; Howard, Steven C.; Hobson, John; Bonsignore, Craig, Expandable slide and lock stent.
    60. Steinke, Thomas A.; Koenig, Donald H.; Zeltinger, Joan, Expandable stent with sliding and locking radial elements.
    61. Swanick, Thomas M.; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul, Fatty-acid based particles.
    62. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Heat cured gel and method of making.
    63. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
    64. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
    65. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steven A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
    66. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Implantable barrier device.
    67. Shanley, John F.; Parker, Theodore L.; Park, Kinam, Implantable medical device with beneficial agent concentration gradient.
    68. Shanley,John F.; Parker,Theodore L., Implantable medical device with drug filled holes.
    69. Dhondt, Maria; De Scheerder, Ivan; Jacobs, Pierre; Martens, Johan, Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent.
    70. Speck, Ulrich; Scheller, Bruno, Medical device for dispensing medicaments.
    71. Speck, Ulrich; Scheller, Bruno, Medical device for dispersing medicaments.
    72. Speck, Ulrich; Scheller, Bruno, Medical device for dispersing medicaments.
    73. Kutryk, Michael J. B.; Cottone, Jr., Robert J.; Rowland, Stephen M., Medical device with coating for capturing genetically-altered cells and methods for using same.
    74. Whitbourne, Richard J.; Chamberlain, Alexandra M.; Hullihen, Daniel G.; Rosebrough, Scott F.; Calistri-Yeh, Mildred, Medicated stent having multi-layer polymer coating.
    75. Whitbourne, Richard J.; Chamberlain, Alexandra M.; Hullihen, Daniel G.; Rosebrough, Scott F.; Calistri-Yeh, Mildred, Medicated stent having multi-layer polymer coating.
    76. Furst, Joseph G.; Patel, Udayan; Buckman, Raymond, Metal alloys for medical devices.
    77. Furst,Joseph G.; Patel,Udayan; Buckman, Jr.,Raymond W., Metal alloys for medical devices.
    78. Corbeil, Scott E.; Labrecque, Roger; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Bromander, Edward; Henrich, Georgette, Method and apparatus for application of a fresh coating on a medical device.
    79. Buckman, Jr., Raymond W.; Patel, Udayan; Furst, Joseph, Method for forming a tubular medical device.
    80. Rossi, Mara, Method for the quantitative determination of poloxamers.
    81. Herweck, Steve A.; Martakos, Paul; Moodie, Geoffrey; Labrecque, Roger; Karwoski, Theodore; Carlton, Trevor; Rogers, Lisa; Ferraro, Joseph, Method of coating a folded medical device.
    82. Herweck, Steve A.; Martakos, Paul; Moodie, Geoffrey; Labrecque, Roger; Karwoski, Theodore; Carlton, Trevor; Rogers, Lisa; Ferraro, Joseph, Method of coating a folded medical device.
    83. Sequin, Jacques; Elicker, Robert John; Laborde, Jean-Claude, Noncylindrical stent deployment system for treating vascular bifurcations.
    84. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated bioabsorbable oil film and methods for making the same.
    85. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated fatty acid films.
    86. Speck, Ulrich; Scheller, Bruno, Preparation for restenosis prevention.
    87. Speck, Ulrich; Scheller, Bruno, Preparation for restenosis prevention.
    88. Speck, Ulrich; Scheller, Brunn, Preparation for the prophylaxis of restenosis.
    89. Furst, Joseph G.; Patel, Udayan; Buckman, Jr., Raymond W., Process for forming an improved metal alloy stent.
    90. Cottone, Jr., Robert John; Yoklavich, Margaret; Parker, Sherry, Progenitor endothelial cell capturing with a drug eluting implantable medical device.
    91. Weier, Keith; Howard, Steven C., Reduced-profile slide and lock stent.
    92. Schmid, Eric V.; Nguyen, John D.; Howard, Steven C.; Padilla, Orlando M.; Morris, Andrew; Eisele, Robert F.; DiPari, Joseph Anthony; Matsuura, David G.; Simpson, Philip J.; Gillespie, Walter D.; Moore, Daniel; Jackson, Thomas R.; Zeltinger, Joan; Esser, Keith Allen; Brandom, Donald K., Slide-and-lock stent.
    93. Schmid, Eric V.; Nguyen, John D.; Howard, Steven C.; Padilla, Orlando M.; Morris, Andrew; Eisele, Robert F.; Moore, Daniel; Jackson, Thomas R.; Zeltinger, Joan, Slide-and-lock stent.
    94. Schmid, Eric; Morris, Andrew; Nguyen, John D., Slide-and-lock stent.
    95. Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Stand-alone film and methods for making the same.
    96. Furst, Joseph G., Stent coating.
    97. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John, Stent delivery system having a fibrous matrix covering with improved stent retention.
    98. Ehrenreich, Kevin J.; Newhauser, Richard; von Oepen, Randolf; Stankus, John J., Stent delivery system having a fibrous matrix covering with improved stent retention.
    99. Alt, Eckhard, Stent device and method.
    100. Shanley,John F., Stent wall structure.
    101. Shanley,John F., Stent wall structure.
    102. Toleikis, Philip M., Stents combined with paclitaxel derivatives.
    103. Furst, Joseph G., Sutures and surgical staples for anastamoses, wound closures, and surgical closures.
    104. Schoenle, Victor Leo; Piippo Svendsen, Cassandra Ann; Tibesar Jensen, Kristina; Oreschnick, Mark B.; Borrell, Alyson M., Systems and methods for mixing therapeutic agents before and/or during administration.
    105. Whitbourne, Richard J.; Hullihen, Daniel; Violante, Michael R.; Wang, Frank Guo-Bin; Zhang, Xianping, Targeted therapeutic agent release devices and methods of making and using the same.
    106. Shanley, John F.; Parker, Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    107. Shanley,John F.; Parker,Theodore L., Therapeutic agent delivery device with controlled therapeutic agent release rates.
    108. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    109. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    110. Kunz, Lawrence L.; Anderson, Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
    111. Kunz, Lawrence L.; Klein, Richard A.; Reno, John M., Therapeutic inhibitor of vascular smooth muscle cells.
    112. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Tissue separating device with reinforced support for anchoring mechanisms.
    113. Swanick, Thomas M.; Bienkiewicz, Joe; Ferraro, Joseph; Martakos, Paul; Faucher, Keith M.; Dale, Alicia, Tissue-separating fatty acid adhesion barrier.
    114. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; Swanick, Thomas M., UV cured gel and method of making.
    115. Liao, James K., Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization.
    116. Furst,Joseph G.; Brodbeck,William, Vascular grafts with amphiphilic block copolymer coatings.

    문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로